NASDAQ:MBIO - Mustang Bio Stock Price, Forecast & News

Mustang Bio trades on the NASDAQ under the ticker symbol "MBIO."

Mustang Bio Inc (NASDAQ:MBIO) announced its quarterly earnings data on Tuesday, November, 12th. The company reported ($0.25) EPS for the quarter, beating the consensus estimate of ($0.26) by $0.01. View Mustang Bio's Earnings History.

Mustang Bio is scheduled to release their next quarterly earnings announcement on Monday, March 16th 2020. View Earnings Estimates for Mustang Bio.

3 analysts have issued twelve-month price objectives for Mustang Bio's stock. Their forecasts range from $7.00 to $18.00. On average, they anticipate Mustang Bio's share price to reach $10.67 in the next year. This suggests a possible upside of 169.4% from the stock's current price. View Analyst Price Targets for Mustang Bio.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Mustang Bio in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Mustang Bio.

Media headlines about MBIO stock have been trending somewhat positive recently, according to InfoTrie. The research group identifies positive and negative press coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Mustang Bio earned a news impact score of 1.0 on InfoTrie's scale. They also gave headlines about the company a news buzz of 3.0 out of 10, indicating that recent press coverage is unlikely to have an impact on the company's share price in the immediate future. View News Stories for Mustang Bio.

Some companies that are related to Mustang Bio include Urogen Pharma (URGN), Molecular Templates (MTEM), Phoenix Tree (IMAB), Atreca (BCEL), ZIOPHARM Oncology (ZIOP), XBiotech (XBIT), Crinetics Pharmaceuticals (CRNX), Clovis Oncology (CLVS), Kura Oncology (KURA), AC Immune (ACIU), Axovant Sciences (AXON), Ardelyx (ARDX), Puma Biotechnology (PBYI), Assembly Biosciences (ASMB) and MacroGenics (MGNX).

Based on aggregate information from My MarketBeat watchlists, some companies that other Mustang Bio investors own include Agile Therapeutics (AGRX), Zynerba Pharmaceuticals (ZYNE), Melinta Therapeutics (MLNT), Sorrento Therapeutics (SRNE), Aduro BioTech (ADRO), Fortress Biotech (FBIO), Nabriva Therapeutics (NBRV), TG Therapeutics (TGTX), Anavex Life Sciences (AVXL) and Corbus Pharmaceuticals (CRBP).

Mustang Bio's stock is owned by a number of of institutional and retail investors. Top institutional investors include Renaissance Technologies LLC (1.89%), State Street Corp (1.22%), Geode Capital Management LLC (0.95%), Ikarian Capital LLC (0.80%), Parkman Healthcare Partners LLC (0.75%) and Oxford Asset Management LLP (0.56%). View Institutional Ownership Trends for Mustang Bio.

MBIO stock was sold by a variety of institutional investors in the last quarter, including Acadian Asset Management LLC and Bank of America Corp DE. View Insider Buying and Selling for Mustang Bio.

MBIO stock was acquired by a variety of institutional investors in the last quarter, including Ikarian Capital LLC, Parkman Healthcare Partners LLC, Oxford Asset Management LLP, Renaissance Technologies LLC, National Asset Management Inc., FNY Investment Advisers LLC, UBS Group AG and State Street Corp. View Insider Buying and Selling for Mustang Bio.

Shares of MBIO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of MBIO stock can currently be purchased for approximately $3.96.

Mustang Bio has a market capitalization of $160.62 million. The company earns $-30,660,000.00 in net income (profit) each year or ($1.14) on an earnings per share basis. Mustang Bio employs 38 workers across the globe.View Additional Information About Mustang Bio.

The official website for Mustang Bio is http://www.mustangbio.com/.

Mustang Bio's mailing address is 2 GANSEVOORT STREET 9TH FLOOR, NEW YORK NY, 10014. The company can be reached via phone at 781-652-4500 or via email at [email protected]